| Literature DB >> 26149519 |
Abstract
BACKGROUND: We performed a systematic review of the efficacy of various types of acupuncture in the treatment of asthma in children.Entities:
Mesh:
Year: 2015 PMID: 26149519 PMCID: PMC4491888 DOI: 10.1186/s13052-015-0155-1
Source DB: PubMed Journal: Ital J Pediatr ISSN: 1720-8424 Impact factor: 2.638
Fig. 1Flow diagram of study selection
Characteristics of included studies
| Author (year) | Study design | Patients | Stage of asthma | Number of patients | Age years (mean ± SD) | Gender M/F | Intervention | Acupoint(s) |
|---|---|---|---|---|---|---|---|---|
| Karlson and Bennicke (2013) [ | RCT | Children ages 6 months to 6 years with asthma | NA | 64 | 2.8 ± 1.6 | NA | Acupuncture + acupressure: 10 sessions (1.5 h each) over a period of 3 months | Acupuncture: LIV (liver) 2 |
| Acupressure: LU 7, REN 17, REN 22, LI 4, PC 6, SP 6, SP 10, ST 36, ST 40, K 3, K 7, DU 14, DU 20, Dingchuan | ||||||||
| 58 | 2.2 ± 1.1 | Control: No acupuncture | None | |||||
| Scheewe et al. (2011) [ | RCT | Children and adolescents ages 12-17 years with bronchial asthma | NA | 46 | Male: 14.6 ± 1.8 | 26/20 | Acupuncture: Total of 12 sessions (30 min each) over a 4-week period | Bilateral bladder 13; bilateral conception vessel 17; bilateral lung 7; plus 2-6 additional points |
| Female: 15.0 ± 2.1 | ||||||||
| 47 | Male: 13.7 ± 1.2 | 25/22 | Control: No acupuncture | None | ||||
| Female: 16.2 ± 1.7 | ||||||||
| Nedeljković et al. (2008) [ | RCT | Children ages 7-17 years with asthma | Acute bronchial obstruction | 50 | 11 | 25/25 | Su Jok therapy (laser at acupuncture points in hand): Total 10 sessions (5 each week except for weekends over 12 days) | According to the 6-Ki Su Jok principles |
| 50 | 25/25 | Control: No acupuncture | None | |||||
| Stockert et al. (2007) [ | RCT | Children ages 6-12 years with asthma | Intermittent or mild | 7 | 9.4 ± 2.4 | NA | Laser acupuncture (10 treatments of laser acupuncture on a once-weekly schedule) + probiotic drops (20 drops 3 times daily for 7 weeks) | Lung 1, 5, 7, 9, 11; large intestine 4, 6, 19, 20; bladder 13, 17, 18, 20, 21, 23; stomach 13, 25, 36, 40, 44; spleen 3, 6, 9, 10; heart 3, 5, 7; small intestine 3; kidney 3, 6, 8, 27; pericardium 6; triple heater 5, 15; gallbladder 3, 34, 40, 41; liver 2, 3, 8, 13; Yintang, Dingchuan; conception vessel 4, 6, 9, 17, 21; governor vessel 4, 13 |
| 9 | 10.0 ± 1.9 | Control: 10 placebo laser acupuncture sessions + placebo drops | No laser light | |||||
| Gruber et al. (2002) [ | RCT, crossover | Children with exercise-induced asthma | Mild to moderate | 44 | 11.9 ± 2.6 | 26/18 | Laser acupuncture: Single treatment | Yintang (EX 1), Chize (LU 5), Lieque (LU 7), Feishu (UB 13), Geshu (UB 17), and Shanzhong (CV 17) |
| Control: Laser acupuncture at placebo points; single treatment | Baihui (GV 20), Quze (PE 3), Neiguan (PE 6), Dashu (UB 11), Weishu (UB 21), and Zhongwan (CV 12) | |||||||
| Fung et al. (1986) [ | RCT, crossover | Children with exercise-induced asthma | Mild to moderate | 19 | Range 9-13.5 | NA | Acupuncture: Applied 20 min before exercise | Dingchuan (extra 17), kongzui (L6), and taixi (K3) |
| NA | Control: No acupuncture or acupuncture applied at placebo points 20 min before exercise | Placebo points: Jianwaishu (SI14), ximen (P4), and xuanzhong (G39) | ||||||
| Chow et al. (1983) [ | RCT, crossover | Children with exercise-induced asthma | NA | 16 | 11 (range 8-13) | NA | Acupuncture: Applied 10 min before exercise (once per week for 2 weeks) | Auricular lung point |
| Control: No acupuncture (baseline) or acupuncture applied at placebo point | Auricular lumbago point |
F, female; M, male; NA, not available/applicable; RCT, randomized controlled trial; SD, standard deviation
Outcomes for lung function parameters (data reported for six of seven studies)
| Author (year) | Intervention | FEV1 | FVC | PEF | MEF | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mean ± SD, or % | Mean ± SD, or % | Mean ± SD, or % | Mean ± SD, or % | ||||||||||
| Before | After | Change | Before | After | Change | Before | After | Change | Before | After | Change | ||
| Scheewe et al. (2011) [ | Acupuncture | – | – | – | FEV1/FVC | FEV1/FVC | – | PEF variability 16.1 % ± 8.3 % | PEF variability 12.5 % ± 5.5 % * | – | MEF50 88.5 % ± 26.8 % | MEF50 89.2 % ± 26.1 % | – |
| 84.6 ± 9.0 | 85.4 ± 8.6 | ||||||||||||
| No acupuncture | – | – | – | FEV1/FVC | FEV1/FVC | – | PEF variability 20.4 % ± 9.4 % | PEF variability 16.9 % ± 8.8 % | – | MEF50 86.8 % ± 27.9 % | MEF50 86.2 % ± 23.1 % | – | |
| 84.6 ± 10.1 | 84.9 ± 8.3 | ||||||||||||
| Nedeljković et al. (2008) [ | Su Jok therapy (laser) | 51 % | 84 % * | – | 62 % | 90 % * | – | 65 % | 96 % * | – | – | – | – |
| No acupuncture | 58 % | 74 % | – | 70 % | 86 % | – | 64 % | 78 % | – | – | – | – | |
| Stockert et al. (2007) [ | Laser acupuncture | 81.8 % ± 8.1 % | 86.3 % ± 5.7 % | – | – | – | – | PEF variability 25.2 % ± 16.2 % | PEF variability 7.9 % ± 2.9 % * | – | – | – | – |
| Placebo acupuncture | 81.5 % ± 8.0 % | 88.6 % ± 8.5 % | – | – | – | – | PEF variability 15.5 % ± 1.8 % | PEF variability 17.8 % ± 23.9 % | – | – | – | – | |
| Gruber et al. (2002) [ | Laser acupuncture | 98.5 % ± 9.8 % | 84.2 % ± 15.3 % | 14.9 % ± 14.1 %§ | – | – | – | – | – | – | MEF25 78.6 % ± 23.1 % | MEF25 56.3 % ± 24.5 % | MEF25 29.7 % ± 23.2 % § |
| Placebo acupuncture | 97.8 % ± 11.0 % | 86.2 % ± 12.6 % | 12.4 % ± 10.2 %§ | – | – | – | – | – | – | MEF25 78.4 % ± 26.1 % | MEF25 57.3 % ± 23.1 % | MEF25 28.9 % ± 21.3 % § | |
| Fung et al. (1986) [ | Acupuncture | – | – | 23.78 % ± 19.46 % *¶ | – | – | 15.80 % ± 20.71 % ¶ | – | – | 25.90 ± 20.76 % *¶ | – | – | – |
| Placebo acupuncture | – | – | 32.63 % ± 19.99 % *¶ | – | – | 26.13 % ± 17.76 % ¶ | – | – | 34.34 ± 18.97 % *¶ | – | – | – | |
| No acupuncture | – | – | 44.38 % ± 16.88 % ¶ | – | – | 33.25 % ± 21.37 % ¶ | – | – | 49.54 % ± 17.25 % ¶ | – | – | – | |
| Chow et al. (1983) [ | Acupuncture | 1.53 L (SEM: 0.09 L) | 1.14 L (SEM: 0.12 L) | 27.5 % (SEM: 5.36 % ¶) | – | – | – | – | – | – | – | – | – |
| Placebo acupuncture | 1.50 L (SEM: 0.07 L) | 1.02 L (SEM: 0.10 L) | 31.9 % (SEM: 7.98 % ¶) | – | – | – | – | – | – | – | – | – | |
| No acupuncture | 1.55 L (SEM: 0.07 L) | 0.92 L (SEM: 0.07 L) | 40.2 % (SEM: 10.0 % ¶) | – | – | – | – | – | – | – | – | – | |
*,Significant difference between groups
†, Data from this study are estimated from graphically presented values
‡, Data from this study are presented as % predicted values
§, Percent fall postacupuncture to 15 min after cold dry air challenge
¶, Attenuation of exercise-induced asthma as measured by percent fall in FEV1, FVC, or PEF
–, Not reported
FEV1, forced exhaled volume in 1 s; FVC, forced vital capacity; MEF, maximum expiratory flow (at 50 % or 25 % of the FVC); PEF, peak expiratory flow; SD, standard deviation
Outcomes for medication use, symptoms, and quality of life (data reported for three of seven studies)
| Author (year) | Intervention | Medication use | Symptoms | Quality of life | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mean ± SD | |||||||||||
| Before | After | Follow-up | Before | After | Follow-up | Before | After | Follow-up | Scale used | ||
| Karlson and Bennicke (2013) [ | Acupuncture | β-mimetics (puffs/24 h) 2.2 ± 2.1 | β-mimetics (puffs/24 h) 0.7 ± 1.1 | β-mimetics (puffs/24 h) 0.4 ± 1.0 | *Significant reduction in symptoms between groups at 3 months; however, no significant difference at 12 months | – | – | – | – | ||
| IHS (μg/day)537 ± 260 | IHS (μg/day) 126 ± 209* | ||||||||||
| No acupuncture | β-mimetics (puffs/24 h) 2.8 ± 4.2 | β-mimetics (puffs/24 h) 0.9 ± 1.3 | β-mimetics (puffs/24 h) 0.5 ± 1.0 | – | – | – | – | ||||
| IHS (μg/day) 477 ± 271 | IHS (μg/day) 342 ± 287 | ||||||||||
| Scheewe et al. (2011) [ | Acupuncture | Controller (frequency/ day) 1 use: 23 | Controller (frequency/ day) 1 use: 9 | Controller (frequency/ day) 1 use: 4 | (Per day) Morning: 18 Day: 19 | (Per day) Morning: 13 Day: 13 | (Per day) Morning: 18 Day: 18 | Overall: 3.8 ± 0.7 | Overall: 4.3 ± 0.5 | Overall: 4.2 ± 0.6 | PAQLQ |
| Activity: 3.2 ± 0.9 | Activity: 4.0 ± 0.8 | Activity: 3.9 ± 1.0 | |||||||||
| Symptom: 3.5 ± 0.9 | Symptom: 4.2 ± 0.7 | Symptom: 3.9 ± 0.9 | |||||||||
| ≧2 uses: 18 | ≧2 uses: 25 | ≧2 uses: 36 | Night: 10 | Night: 7 | Night: 9 | Emotion: 3.8 ± 1.0 | Emotion: 4.5 ± 0.6 | Emotion: 4.3 ± 0.9 | |||
| Trait: 32.4 ± 5.8 | Trait: 32.5 ± 8.2 | Trait: 29.1 ± 7.3 | STAIC | ||||||||
| State: 41.5 ± 8.1 | State: 38.4 ± 8.7* | State: 37.6 ± 8.2 | |||||||||
| No acupuncture | Controller (frequency/day) 1 use: 30 | Controller (frequency/ day) 1 use: 9 | Controller (frequency/ day) 1 use: 6 | (Per day) Morning: 13 Day: 11 | (Per day) Morning: 11 Day: 14 | (Per day) Morning: 18 Day: 15 | Overall: 3.4 ± 0.8 | Overall: 4.1 ± 0.6 | Overall: 3.9 ± 0.9 | PAQLQ | |
| Activity: 3.2 ± 0.8 | Activity: 4.2 ± 0.7 | Activity: 4.0 ± 0.7 | |||||||||
| Symptom: 3.7 ± 0.8 | Symptom: 4.2 ± 0.6 | Symptom: 4.1 ± 0.8 | |||||||||
| ≧2 uses: 13 | ≧2 uses: 26 | ≧2 uses: 34 | Night: 4 | Night: 4 | Night: 9 | Emotion: 4.0 ± 0.9 | Emotion: 4.5 ± 0.6 | Emotion: 4.3 ± 0.7 | |||
| Trait: 36.4 ± 8.9 | Trait: 33.6 ± 10.0 | Trait: 30.4 ± 9.5 | STAIC | ||||||||
| State: 45.2 ± 8.8 | State: 44.4 ± 9.2 | State: 42.5 ± 10.3 | |||||||||
| Stockert et al. (2007) [ | Laser acupuncture | β-mimetics (puffs/week) | β-mimetics (puffs/week) | – | – | – | – | 62.1 ± 20 | 54.9 ± 25.4 | 49.3 ± 23.8 | ACQ |
| 8.7 ± 15.4 | 9.1 ± 15.4 | ||||||||||
| Placebo acupuncture | β-mimetics (puffs/week) | β-mimetics (puffs/week) | – | – | – | – | 47.8 ± 9.5 | 34.6 ± 16.6 | 38.7 ± 17.1 | ||
| 3.1 ± 6.2 | 3.7 ± 6.7 | ||||||||||
*,Significant difference between groups
–, Not reported
IHS, inhaled steroids; PAQLQ, Paediatric Asthma Quality of Life Questionnaire; STAIC, State-trait anxiety inventory for children; ACQ, Asthma Control Questionnaire
Quality assessment of included studies
| Author (year) | Random sequence generation (selection bias) | Allocation concealment (selection bias) | Blinding of participants and personnel (performance bias) | Blinding of outcome assessment (detection bias) | Incomplete outcome data (attrition bias) | Selective reporting (reporting bias) | Did the analysis include an intent-to-treat analysis? |
|---|---|---|---|---|---|---|---|
| Karlson and Bennicke (2013) [ | Y | NA | N | N | Y | Y | NA |
| Scheewe et al. (2011) [ | Y | NA | N | NA | Y | Y | NA |
| Nedeljković et al. (2008) [ | Y | NA | N | NA | NA | Y | NA |
| Stockert et al. (2007) [ | Y | Y | Y | Y | Y | Y | N |
| Gruber et al. (2002) [ | Y | NA | Y | Y | NA | Y | NA |
| Fung et al. (1986) [ | Y | NA | Y | N | NA | Y | NA |
| Chow et al. (1983) [ | Y | NA | Y | N | NA | Y | NA |
NA, not available; N, no; Y, yes